BRIEF-Tempest Lays Out Strategic Plan To Advance Recently Acquired Dual-Targeting Car-T Assets

Tempest Therapeutics, Inc. 0.00%

Tempest Therapeutics, Inc.

TPST

2.31

0.00%

- Tempest Therapeutics Inc TPST.O:

  • TEMPEST LAYS OUT STRATEGIC PLAN TO ADVANCE RECENTLY ACQUIRED DUAL-TARGETING CAR-T ASSETS

  • TEMPEST THERAPEUTICS INC - PRIORITIZES TPST-2003 AND EXPANDS WITH TPST-4003

  • TEMPEST THERAPEUTICS INC - EXPECTS PHASE 2B INITIATION FOR TPST-2003 BY 2026 IN CHINA

  • TEMPEST THERAPEUTICS INC - TO INITIATE PHASE 2 STUDY OF TPST-1495 IN Q1 2026

  • TEMPEST THERAPEUTICS INC - PLANS TO PROGRESS ADDITIONAL DUAL TARGETING TPST-3003 CAR-T PROGRAM

Source text: ID:nGNX8ry0RW

Further company coverage: TPST.O


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via